IL2 and neoplasm: While the latter study, which used cells expressing a CD62L+ Tcm-like phenotype similar to the cells tested here, lymphodepletion and administration of IL-2 was also employed and the authors attribute reduction of MDSC as reported by others [51] at the tumour site with key role in the outcome.